The benefit of population-based PSA screening for men with an average risk of prostate cancer does not outweigh the harm caused. This is the conclusion drawn by the Institute for Quality and ...
A new blood-based screening test could significantly improve the detection of aggressive prostate cancer compared with the widely used prostate-specific antigen (PSA) test, according to a new ...